InvestorsHub Logo
Followers 4
Posts 589
Boards Moderated 0
Alias Born 03/07/2003

Re: AVII77 post# 192194

Sunday, 05/19/2019 11:09:35 PM

Sunday, May 19, 2019 11:09:35 PM

Post# of 426573
A classic case of subgroup analysis leading to a colossal failure is Galena Biopharma‘s phase 3 disappointment after plucking a single subgroup from a failed phase 2 and designing a phase 3 around that population.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News